COMPANY PROFILE / #671
Biolinq
Developer of a biomonitoring health platform designed to improve metabolic health. The company's platform offers a skin-applied, minimally invasive electrochemical biosensor with a potential for multiple analytes, such as glucose, ketones, and lactate, and provides actionable metabolic health insights from multi-analyte wearable sensors, providing patients with personalized health insights and supporting advancements in medicine.Privately Held (backing)
已融资125
最新估值—
员工数—
成立年份Senseonics Holdings, GlucoWise, GlySens, DexCom, GWave
公司概况
- Companies
- Biolinq
- Description
- —
- Website
- San Diego, CA
- HQ Location
- Developer of a biomonitoring health platform designed to improve metabolic health. The company's platform offers a skin-applied, minimally invasive electrochemical biosensor with a potential for multiple analytes, such as glucose, ketones, and lactate, and provides actionable metabolic health insights from multi-analyte wearable sensors, providing patients with personalized health insights and supporting advancements in medicine.
- Year Founded
- Senseonics Holdings, GlucoWise, GlySens, DexCom, GWave
- Keywords
- 2026: 125, 2025: 107, 2024: 101, 2023: 93, 2022: 30, 2021: 60, 2020: 27, 2019: 6, 2018: 7 E, 2017: 7, 2016: 5
- Competitors
- —
- Ownership Status
- —
- Company Financing Status
- Privately Held (backing)
融资与估值
- Total Raised
- 125
- First Financing Date
- —
- First Financing Size
- 9
- First Financing Valuation
- jared@biolinq.me
- Last Financing Date
- -0.34%
- Last Financing Deal Type
- 23-Apr-2025
- Last Financing Size
- Later Stage VC
- Last Financing Valuation
- —
- Last Financing Status
- 407.00
- Last Known Valuation
- —
- Last Known Valuation Date
- Later Stage VC
- Last Known Valuation Deal Type
- —
- Valuation Estimate
- 23-Apr-2025
- Valuation Estimate Growth Rate
- blood glucose monitor, connected healthcare, electrochemical sensors, glucose monitoring device, health monitoring, healthcare market, metabolic care, personalized care
- Active Investors
- Venture Capital-Backed
- # Active Investors
- 4%
- Acquirers
- Able Partners, Alpha Wave Global, Aphelion Capital, Ascensia Diabetes Care, Averin, AXA IM Alts, AXA Investment Managers, Biobrit, Cirrus Logic, CONNECT (San Diego), Endo Investors, EOFlow, EvoNexus, Features Capital, G9 Ventures, Global Health Investment Corporation, Hikma Ventures, Institute for the Global Entrepreneur, LifeSci Venture Partners, Longevity Vision Fund, M Ventures, Mark Cuban, MedTech Innovator, National Institutes of Health, Nebraska Angels, Pegasus Tech Ventures, RiverVest Venture Partners, Senvest Capital, Standish Spring Investments, T&W Medical, T1D Fund, Taisho Pharmaceutical, The Broe Group, Three Leaf Ventures, U.S. Department of Health and Human Services, Venture Lab Niterra Group
团队与联系人
- Employees
- —
- Employee Growth %
- 2012
- Employee History
- —
- Primary Contact
- 312.79
- Primary Contact Title
- +1 (510) 847-9655
- Primary Contact Email
- Jared Tangney
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- 85.10%
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- 216
- Size Multiple
- —
- Size Multiple % Change
- 407.00
- Size Multiple Change
- 0.00%
- Size Multiple Percentile
- 0.00x
- Majestic Referring Domains
- 8.31x
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- 1,845
- Success Probability Over Time – 1 Year
- 11%
- Success Probability Over Time – 3 Year
- 22%
- Success Probability Over Time – 5 Year
- Co-Founder, Chief Technology Officer & President
记录来源：public.companies · 原始序号 #671 · 所有字段均按数据库原值展示。